MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 135 filers reported holding MACROGENICS INC in Q1 2018. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $269,511 | -21.9% | 57,835 | -10.4% | 0.00% | – |
| Q2 2023 | $345,267 | +40.7% | 64,536 | +88.5% | 0.00% | – |
| Q1 2023 | $245,479 | +7.1% | 34,237 | +0.3% | 0.00% | – |
| Q4 2022 | $229,120 | +94.2% | 34,146 | +0.1% | 0.00% | – |
| Q3 2022 | $118,000 | -98.6% | 34,110 | -92.6% | 0.00% | -100.0% |
| Q1 2019 | $8,259,000 | +41.6% | 459,335 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $5,834,000 | -40.8% | 459,335 | 0.0% | 0.00% | -20.0% |
| Q3 2018 | $9,848,000 | -0.6% | 459,335 | -4.2% | 0.01% | 0.0% |
| Q2 2018 | $9,904,000 | -17.9% | 479,615 | +0.0% | 0.01% | -16.7% |
| Q1 2018 | $12,064,000 | +32.4% | 479,500 | 0.0% | 0.01% | +50.0% |
| Q4 2017 | $9,111,000 | -1.8% | 479,500 | -4.5% | 0.00% | -20.0% |
| Q3 2017 | $9,275,000 | +5.5% | 501,900 | 0.0% | 0.01% | +25.0% |
| Q2 2017 | $8,788,000 | -19.5% | 501,900 | -14.5% | 0.00% | -33.3% |
| Q1 2017 | $10,920,000 | -9.0% | 587,100 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $12,000,000 | -33.0% | 587,100 | -2.0% | 0.01% | -33.3% |
| Q3 2016 | $17,910,000 | +10.8% | 598,800 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $16,162,000 | +44.9% | 598,800 | +0.6% | 0.01% | +50.0% |
| Q1 2016 | $11,156,000 | -39.5% | 595,000 | 0.0% | 0.01% | -33.3% |
| Q4 2015 | $18,427,000 | +39.2% | 595,000 | -3.7% | 0.01% | +28.6% |
| Q3 2015 | $13,238,000 | -52.0% | 618,000 | -14.9% | 0.01% | -46.2% |
| Q2 2015 | $27,570,000 | +21.0% | 726,100 | 0.0% | 0.01% | +30.0% |
| Q1 2015 | $22,778,000 | -4.1% | 726,100 | +7.2% | 0.01% | -9.1% |
| Q4 2014 | $23,753,000 | +124.0% | 677,300 | +33.5% | 0.01% | +120.0% |
| Q3 2014 | $10,603,000 | -10.3% | 507,300 | -6.7% | 0.01% | 0.0% |
| Q2 2014 | $11,819,000 | -8.9% | 543,900 | +16.6% | 0.01% | -16.7% |
| Q1 2014 | $12,980,000 | +20.3% | 466,400 | +18.5% | 0.01% | +20.0% |
| Q4 2013 | $10,794,000 | – | 393,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,264,158 | $5,890,976 | 1.79% |
| Bellevue Group AG | 9,803,313 | $45,683,439 | 0.74% |
| Frazier Life Sciences Management, L.P. | 1,803,204 | $8,402,931 | 0.56% |
| DAFNA Capital Management LLC | 258,496 | $1,204,591 | 0.38% |
| SECTORAL ASSET MANAGEMENT INC | 387,001 | $1,803,425 | 0.35% |
| ARMISTICE CAPITAL, LLC | 4,712,000 | $21,957,920 | 0.34% |
| Rock Springs Capital Management LP | 1,178,796 | $5,493,189 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 225,918 | $1,053 | 0.09% |
| PINNACLE ASSOCIATES LTD | 697,067 | $3,248,332 | 0.06% |
| XTX Topco Ltd | 53,269 | $248,234 | 0.04% |